SELECT-3: a phase I study of selumetinib in combination with platinum-doublet chemotherapy for advanced NSCLC in the first-line setting.-论文-万方医学网

作者： Alastair,Greystoke ^[1] ; Nicola,Steele ^[2] ; Hendrik-Tobias,Arkenau ^[3] ; Fiona,Blackhall ^[4] ; Noor,Md Haris ^[5] ; Colin R,Lindsay ^[1] ; Raffaele,Califano ^[2] ; Mark,Voskoboynik ^[5] ; Yvonne,Summers ^[3] ; Karen,So ^[5] ; Dana,Ghiorghiu ^[6] ; Angela W,Dymond ^[6] ; Stuart,Hossack ^[7] ; Ruth,Plummer ^[8] ; Emma,Dean ^[1]

作者单位： Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, UK. ^[1] The Beatson West of Scotland Cancer Centre, Glasgow, UK. ^[2] Sarah Cannon Research Institute UK, London, UK. ^[3] University College London, London, UK. ^[4] The Christie Hospital NHS Foundation Trust, Manchester, UK. ^[5] AstraZeneca, Cambridge, UK. ^[6] AstraZeneca, Macclesfield, UK. ^[7] Covance, Leeds, UK. ^[8]

主题词成年人(Adult);老年人(Aged);贫血(Anemia);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);苯咪唑类(Benzimidazoles);卡铂(Carboplatin);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);顺铂(Cisplatin);脱氧胞苷(Deoxycytidine);腹泻(Diarrhea);鼻出血(Epistaxis);疲劳(Fatigue);女(雌)性(Female);人类(Humans);嗜睡(Lethargy);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);恶心(Nausea);蛋白激酶抑制剂(Protein Kinase Inhibitors);血小板减少(Thrombocytopenia);呕吐(Vomiting)

DOI 10.1038/bjc.2017.271

PMID 28950288

发布时间 2024-02-10

检索历史清除

SELECT-3: a phase I study of selumetinib in combination with platinum-doublet chemotherapy for advanced NSCLC in the first-line setting.

British journal of cancer

相似文献

British journal of cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

SELECT-3: a phase I study of selumetinib in combination with platinum-doublet chemotherapy for advanced NSCLC in the first-line setting.

British journal of cancer

相似文献

British journal of cancer

相关期刊

检索历史清除